13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuropsychiatry
Neuropsychiatry examines the intricate relationship between the brain and psychiatric disorders, focusing on how neurological factors contribute to mental health conditions. By studying the brain’s structure, function, and biochemical processes, neuropsychiatry seeks to explain how diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis can manifest with psychiatric symptoms such as mood swings, hallucinations, and cognitive decline. The field bridges psychiatry and neurology, offering a holistic approach to treating patients whose conditions involve both psychological and neurological components. Innovative approaches in neuropsychiatry, including neuroimaging and neurogenetics, are shedding light on the underlying mechanisms of psychiatric disorders, leading to more effective treatment strategies. This evolving field holds promise for improving outcomes for patients who suffer from disorders that were once considered solely psychiatric or neurological.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Ananya Rajasekaran, ThinkNeuro, United States